Nail Strengthen Cream

Manufacturer
Shenzhen Hengkaifeng Commerce and Trade Co., Ltd
Effective date
2024-08-12
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 00:17:06

Label at a glance#

ProductNail Strengthen Cream
Active ingredientTOLNAFTATE
Label structure11 sections

Indications and uses

Uses for relief and treatment of pain,soreness, and inflammation from nail fungus. Symptoms: ■ discolored nails ■ brittle nails ■ distorted nails

Label contents#

Full prescribing information#

Active ingredients

OTC - ACTIVE INGREDIENT SECTION

Tolnaftate ≤1%

PURPOSE

OTC - PURPOSE SECTION

Anti-fungal

Uses

INDICATIONS & USAGE SECTION

Uses for relief and treatment of pain,soreness, and inflammation from nail fungus.
Symptoms: ■ discolored nails ■ brittle nails ■ distorted nails

Warnings

WARNINGS SECTION

For external use only, some people may be sensitive to essential oils.
to determine if the product may cause any irritation. Discontinue use if any irritation occurs.
If condition worsens, discontinue use and consult a physician. Not suitable for use by children under 2 years of age without a physician's guidance.

Stop use and ask a doctor if

OTC - STOP USE SECTION

rash occur

Do not use

OTC - DO NOT USE SECTION

on damaged or broken skik

When using this product

OTC - WHEN USING SECTION

Wash and thoroughly dry the affected area.
Three times a day, rub gently onto the affected area.
Wash hands after applying

Keep out of reach of children.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallwed, get medical help or contact a Poison Control Center right away.

inactive ingredients

INACTIVE INGREDIENT SECTION

Water

Propylene Glycol

Hydrogenated Castor Oil

Glycerin

Vena Sativa Peptide

Salvia Miltiorrhiza Leaf Extract

Centella Asiatica Extract

Leonurus Artemisia Powder

Arnica Montana Extract

DOSAGE & ADMINISTRATION

DOSAGE & ADMINISTRATION SECTION

Wash and dry affected area thoroughly before use. Apply gently to affected area 3 times daily.

PRINCIPAL DISPLAY PANEL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

11

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
103951tolnaftate 1 % Topical CreamPSN1
103951tolnaftate 10 MG/ML Topical CreamSCD1
103951tolnaftate 1 % Topical CreamSY1

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
84117-022-012026-01-29C16284748780-149896155-a5e1-586f-e063-e6dba90add901f7c0be2-522d-f694-e063-6294a90ae50a

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
84117-022-01Nail Strengthen Cream20 g in 1 CANISTERCREAM201

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
84117-022NAIL STRENGTHEN CREAM CREAM [SHENZHEN HENGKAIFENG COMMERCE AND TRADE CO., LTD]11 package rows20240814_1f7c0be2-522d-f694-e063-6294a90ae50a.zip

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 3 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
84117-02284117-022-01

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 2 matching rows.

Name, UNII, Kind table
NameUNIIKind
WATER059QF0KO0RIACT
TOLNAFTATE06KB629TKVACTIB

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
1f7c0be2-522e-f694-e063-6294a90ae50a1f7c0be2-522d-f694-e063-6294a90ae50a2024-08-12WarningsExact identifier
spl id: 1f7c0be2-522e-f694-e063-6294a90ae50a
spl set id: 1f7c0be2-522d-f694-e063-6294a90ae50a

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.